Author:
Lohse Martin J.,Grehn Franz
Publisher
Springer Berlin Heidelberg
Reference125 articles.
1. AGIS Investigators (2000) The advanced glaucoma intervention study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol 130:429–440
2. Al-Shahwan S, Al-Torbak AA, Turkmani A, AL-Omran M, Al-Jadaan I, Edward DP (2005) Side-effect profile of brimonidine tartrate in children. Ophthalmology. https://doi.org/10.1016/j.ophtha.2005.06.035
3. American Academy of Ophthalmology, Preferred Practice Pattern Guidelines (2015) Age related macular degeneration. San Francisco, CA, 2015. Age-related macular degeneration PPP – updated 2015. http://www.aao.org/preferred-practice-pattern/age-related-macular-degeneration-ppp-2015
4. Aroney C, Fraser-Bell S, Lamoureux EL, Gillies MC, Lim LL, Fenwick EK (2016) Vision-related quality of life outcomes in the BEVORDEX study: a clinical trial comparing Ozurdex sustained release dexamethasone intravitreal implant and bevacizumab treatment for diabetic macular edema. Invest Ophthalmol Vis Sci 57:5541–5546
5. Asbell PA, Sanfilippo CM, Pillar CM, DeCory HH, Sahm DF, Morris TW (2015) Antibiotic resistance among ocular pathogens in the United States: five-year results from the antibiotic resistance monitoring in ocular microorganisms (ARMOR) surveillance study. JAMA Ophthalmol 133:1445–1454